GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arbutus Biopharma Corp (STU:I9DN) » Definitions » Investments And Advances

Arbutus Biopharma (STU:I9DN) Investments And Advances : €7.98 Mil (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Arbutus Biopharma Investments And Advances?

Arbutus Biopharma's Investments And Advances for the quarter that ended in Mar. 2024 was €7.98 Mil.

Arbutus Biopharma's quarterly Investments And Advances declined from Sep. 2023 (€9.84 Mil) to Dec. 2023 (€5.76 Mil) but then increased from Dec. 2023 (€5.76 Mil) to Mar. 2024 (€7.98 Mil).

Arbutus Biopharma's annual Investments And Advances increased from Dec. 2021 (€31.58 Mil) to Dec. 2022 (€35.27 Mil) but then declined from Dec. 2022 (€35.27 Mil) to Dec. 2023 (€5.76 Mil).


Arbutus Biopharma Investments And Advances Historical Data

The historical data trend for Arbutus Biopharma's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arbutus Biopharma Investments And Advances Chart

Arbutus Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 31.58 35.27 5.76

Arbutus Biopharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.69 10.21 9.84 5.76 7.98

Arbutus Biopharma Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Arbutus Biopharma (STU:I9DN) Business Description

Traded in Other Exchanges
Address
701 Veterans Circle, Warminster, PA, USA, 18974
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.

Arbutus Biopharma (STU:I9DN) Headlines

No Headlines